Atopic DermatitisExplores the epidemiology, etiology, management, and pathophysiological mechanisms of atopic dermatitis. This work identifies potential genetic and environmental factors associated with allergic skin immune responses. It is for dermatologists, allergists, immunologists, pharmaceutical and cosmetic chemists, internists, pediatricians, and others. |
Contents
1 Definition and Diagnosis of Intrinsic Versus Extrinsic Atopic Dermatitis | 1 |
2 Epidemiology | 20 |
3 Psychoimmunology and Evaluation of Therapeutic Approaches | 39 |
4 Socioeconomic Impact of Atopic Dermatitis | 60 |
5 Genetics of Atopic Dermatitis | 72 |
6 Risk Factors for Atopic Dermatitis | 98 |
7 Epidermal Barrier in Atopic Dermatitis | 108 |
8 Mechanisms of Allergic Skin Inflammation | 127 |
16 Eosinophils and Atopic Dermatitis | 287 |
17 Aeroallergens | 315 |
18 Atopic Dermatitis and Foods | 331 |
19 Role of Staphylococcus aureus in Atopic Dermatitis | 353 |
20 Fungal Allergens | 369 |
21 Allergy Diagnosis in Atopic Eczema with the Atopy Patch Test | 384 |
22 Conventional Topical Treatment of Atopic Dermatitis | 398 |
23 Special Aspects in Pediatric Patients | 420 |
9 Animal Models of Atopic Dermatitis | 143 |
10 Pathophysiology of Pruritus | 160 |
Overview | 191 |
12 Keratinocytes | 203 |
13 T Cells in Atopic Dermatitis | 212 |
14 AntigenPresenting Cells | 234 |
15 Mast Cells and Basophils | 250 |
24 Role of Cyclic Nucleotide Phosphodlesterases in Atopic Dermatitis | 430 |
25 Phototherapy for Atopic Dermatitis | 439 |
26 The Psychological Aspects of Atopic Dermatitis | 456 |
27 Topical Macrolide Immunomodulators for Therapy of Atopic Dermatitis | 475 |
28 Chinese Herbal Therapy in Atopic Dermatitis | 498 |
29 Systemic Pharmacotherapy | 517 |
30 Future Perspectives in Atopic Dermatitis | 534 |
Other editions - View all
Common terms and phrases
Acad acid activation addition adult allergens Allergy Clin Immunol antibodies antigen application Arch associated asthma atopic dermatitis atopic eczema atopy aureus barrier basophils blood cause challenge changes chemokine chronic clinical compared corticosteroids cutaneous cytokine decreased demonstrated Derm disease effects eosinophils epidermal evidence exposure expression factors function gene genetic granule histamine human hypersensitivity immune important improvement increased individuals induce infiltration inflammation inflammatory inhibits Invest Dermatol involved itch keratinocytes lesions levels lymphocytes major mast cells measures mechanisms mediators mice mite normal observed patch test patients with atopic peripheral phase positive present prevalence production protein pruritus reactions recent receptor reduced release reported response role scratching sensitization serum severe showed shown significant significantly skin specific stimulation suggest superantigens surface symptoms systemic T-cell tacrolimus therapy tissue topical treatment weeks